GOLDMAN SACHS GROUP INC - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 14 filers reported holding IMMUNE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$5,000
-28.6%
35,767
-1.3%
0.00%
Q4 2016$7,000
-84.1%
36,225
-76.9%
0.00%
Q3 2016$44,000
+76.0%
156,868
+363.6%
0.00%
Q4 2015$25,000
-28.6%
33,837
+13.4%
0.00%
Q3 2015$35,000
-36.4%
29,848
+5.0%
0.00%
Q2 2015$55,000
-8.3%
28,422
-15.5%
0.00%
Q1 2015$60,000
-3.2%
33,616
+2.7%
0.00%
Q4 2014$62,000
-41.0%
32,745
+5.1%
0.00%
Q3 2014$105,00031,1430.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Geduld E E 35,000$68,0000.04%
Bank Pictet & Cie (Europe) AG 12,900$25,0000.02%
Ifrah Financial Services, Inc. 21,956$42,0000.02%
Pine River Capital Management L.P. 250,000$295,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$2,0000.00%
BlackRock Investment Management, LLC 3,245$6,0000.00%
CITIGROUP INC 79$00.00%
GOLDMAN SACHS GROUP INC 28,422$55,0000.00%
MORGAN STANLEY 41$00.00%
BlackRock Institutional Trust Company, N.A. 3,930$8,0000.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders